Overview
Autosomal dominant spondylocostal dysostosis (also known as autosomal dominant SCD or spondylocostal dysostosis type 4) is a rare genetic skeletal disorder characterized by abnormal development of the vertebrae and ribs during embryonic growth. It belongs to the broader group of spondylocostal dysostoses, which are conditions involving segmentation defects of the vertebrae along with rib anomalies. The autosomal dominant form is distinguished from the more commonly described autosomal recessive forms by its inheritance pattern, in which a single copy of the altered gene is sufficient to cause the condition. The disease primarily affects the axial skeleton. Key clinical features include multiple vertebral segmentation defects (such as hemivertebrae, butterfly vertebrae, and vertebral fusions), rib anomalies (including fused, absent, or misaligned ribs), and a shortened trunk with relatively normal limb length. The rib abnormalities can lead to a reduced thoracic volume, which in some cases may cause mild to moderate respiratory insufficiency, particularly in infancy. Scoliosis and kyphosis are commonly observed. The severity of the condition can vary considerably even within the same family, with some individuals being mildly affected while others have more significant skeletal deformities. There is currently no cure for autosomal dominant spondylocostal dysostosis. Management is supportive and symptomatic, focusing on monitoring respiratory function, orthopedic management of spinal deformities (which may include bracing or surgical intervention in severe cases), and regular follow-up to assess growth and skeletal development. Genetic counseling is recommended for affected individuals and their families. Prognosis is generally more favorable than in some recessive forms, though outcomes depend on the severity of thoracic and spinal involvement.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Autosomal dominant spondylocostal dysostosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal dominant spondylocostal dysostosis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal dominant spondylocostal dysostosis.
Community
No community posts yet. Be the first to share your experience with Autosomal dominant spondylocostal dysostosis.
Start the conversation →Latest news about Autosomal dominant spondylocostal dysostosis
No recent news articles for Autosomal dominant spondylocostal dysostosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal dominant spondylocostal dysostosis
What is Autosomal dominant spondylocostal dysostosis?
Autosomal dominant spondylocostal dysostosis (also known as autosomal dominant SCD or spondylocostal dysostosis type 4) is a rare genetic skeletal disorder characterized by abnormal development of the vertebrae and ribs during embryonic growth. It belongs to the broader group of spondylocostal dysostoses, which are conditions involving segmentation defects of the vertebrae along with rib anomalies. The autosomal dominant form is distinguished from the more commonly described autosomal recessive forms by its inheritance pattern, in which a single copy of the altered gene is sufficient to cause
How is Autosomal dominant spondylocostal dysostosis inherited?
Autosomal dominant spondylocostal dysostosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Autosomal dominant spondylocostal dysostosis typically begin?
Typical onset of Autosomal dominant spondylocostal dysostosis is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Autosomal dominant spondylocostal dysostosis?
2 specialists and care centers treating Autosomal dominant spondylocostal dysostosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.